皮肤微生物与益生菌在皮肤疾病诊疗中的应用

皮肤是人体最大的器官,定殖着复杂的微生物群落。大部分微生物是对人体无害的,甚至有些是有益的。皮肤微生物在皮表所接触的外环境影响下,形成了其独特且复杂的菌群结构,同时也受到人体固有免疫和获得性免疫系统的影响,与人体免疫系统共同进化。伴随着分子生物学的发展,皮肤上复杂与庞大的常驻菌群被逐渐认知。对皮肤微生物的深入了解不仅帮助人们了解微生物与皮肤屏障的相互作用机制,也为微生物引起的皮肤疾病的治疗提供有效的策略。本文综述了近年来国内外有关皮肤微生物的研究成果,以及在皮肤疾病和微生物紊乱导致的相关疾病中,益生菌在诊疗过程中的应用。     

Antioxidants for improved skin appearance: Intracellular mechanism,challenges and future strategies

Recent advances in molecular and biochemical processes relevant to the skincare field have led to the development of novel ingredients based on antioxidants that can improve skin health and youthfulness. Considering the plethora of such antioxidants and the many implications for the skin's appearance, this review focuses on describing the critical aspects of antioxidants, including cosmetic functions, intracellular mechanisms and challenges. In particular, specialized substances are suggested for the treatment of each skin condition, such as skin ageing, skin dehydration and skin hyperpigmentation, which treatments can maximize effectiveness and avoid side effects during skin care processes. In addition, this review proposes advanced strategies that either already exists in the cosmetic market or should be developed to improve and optimize cosmetic’ beneficial effects.     

Scientific characterization of subclinical skin changes by noninvasive biophysical methods for development of more efficacious skincare products

In 1966, after finishing only my first year of a residency program, I went to the US to study for 2.5 years with Dr Albert M. Kligman the analysis of functional properties of various skin changes in vivo using aged skin, various types of dermatitis and topically applied steroid-induced atrophy as experimental models. Ten years later, I luckily found that measurements of high frequency conductance and capacitance of the skin enable us to evaluate the skin surface hydration state that determines the softness and smoothness of the skin and in particular to detect even subtle skin changes induced by changes in our environmental or by the application of skincare products and cosmetics. Employing such noninvasive biophysical instruments, I have analyzed the functional properties of normal and abnormal skin changes including subclinical skin changes such as atopic xerosis, senile xerosis, scars and effects of various topical and systemic agents. From these studies it became apparent that as long as a certain level of barrier function was retained skin surface hydration is a more important factor for enjoying a good quality of life. We also succeeded in confirming the effect of corneotherapy, the term so pertinently suggested by Dr Kligman for the beneficial effects of skincare products. We could show that their daily application definitely improves the condition of subclinical skin problems. Further progress in such instrumental analysis of skin properties will greatly aid us in the future in selecting a more desirable skincare product on an individual basis.     

An updated review of clinical methods in the assessment of ageing skin – New perspectives and evaluation for claims support

With the advancement of skin research, today's consumer has increased access to an informed understanding of ageing skin and its appendages, together with a plethora of targeted products to meet such needs. In recent years, increased legislative demands for quality evidential claims support have led not only to the development and validation of clinical methods to measure and quantify ageing skin, but also a clearer understanding of the skin ageing process–especially the impact of both its internal and external environments–as well as a tougher stance on clearly unjustifiable claims. Traditional testing methods used to research and evaluate anti‐ageing products claim to employ sophisticated instruments. Today, however, since the term anti‐ageing can be considered a misnomer, intelligent use of combined more advanced clinical methods has enabled the development of technologically improved consumer products providing enhanced efficacy and targeted performance. Non‐invasive methods for the assessment and quantification of the causes of ageing skin provide tools to the clinical researcher as defined by key clinically observed ageing parameters. Where evidence requires additional support, a number of clinical procedures evaluating ageing skin and hair products are combined with invasive procedures, thus enabling an added value to product claims. As discussed herein, given the enhanced understanding of ageing, we provide an update to our previous reviews of clinical methods used in the assessment of skin ageing, to include the wider aspects of environmental exposure; skin pigmentation; microbiome disturbance; surface topography; colour, radiance, and pH; and structural integrity–all requiring a disciplined approach to their use in dermatological investigations and product claims evidence.     

Human health-promoting interactions between hydrocolloid-structured foods and the gut microbiome in the digestive tract: Editorial

There is a growing interest to overcome such diet-related health issues through the interactions with gut microbiome. A complex network of interactions between nutrition, gut microbiota and health has gradually emerged, which has been rarely explored in its whole. Imbalance of the normal gut microbiota has been linked with gastrointestinal conditions. This editorial highlighted the recent developments in the hydrocolloid-structured foods and the gut microbiome in the digestive tract.     

益生菌对高血压影响的研究进展

肠道菌群在代谢综合征、心血管疾病和结直肠癌等疾病中的研究已经成为焦点,但是肠道微生物与这些疾 病的因果关系以及相应的致病机制尚不清楚。通过分析肠道菌群结构、组成以及代谢活动的变化对高血压的影响, 能够揭示肠道以及肠道微生物的活动与高血压之间的相关性。益生菌是对机体健康产生有益作用的活的微生物,可 以调节肠道微生态的平衡以及肠道微生物的代谢活动,从而对高血压的调节产生影响,进而为以肠道微生物为靶点 干预治疗高血压疾病提供理论参考,同时也为疾病的干预治疗提供新的途径和方法。     

A new makeup remover prepared with a system comprising dual continuous channels (bicontinuous phase) of silicone oil and water

Removing makeup is considered to be the first step in the skincare process. Makeup that has served its purpose is a kind of impurity that should ideally be removed completely to maximize the effects of skincare products applied afterwards. However, the use of silicone resins has significantly improved the long‐lasting property of makeup with the result that makeup can hardly be removed efficiently either with surfactant‐type cleansers like soaps or with oil‐based cleansers like liquid crystalline cleansers. Furthermore, oil‐based makeup removers do not leave the skin feeling fresh but oily, and often have been used in combination with surfactant‐type cleansers. In other words, complete makeup removal and a fresh skin feel are considered to be incompatible in conventional formulation technologies. To obtain compatible systems, we investigated the applicability of a system known as the bicontinuous phase and eventually succeeded in developing a novel system for a makeup remover. This phase can be prepared with a specific composition with a complete hydrophilic‐lipophilic balance in an oil/surfactant/water system by using cyclo‐siloxane, which dissolves silicone resin well. The bicontinuous phase has an oil‐ and water‐continuous microstructure, showing affinity for both aqueous and oily substances. This bicontinuous phase was applied to the development of a novel makeup remover. Determination of remover cap‐ability and fresh skin feel revealed that the makeup could be completely removed and that the amount of oil remaining on skin surface after wash‐off was much less than with previous oil‐based removers. The results of the sensory test also supported the finding that the remover was far superior to conventional products. This makeup remover is the first example of the application of the bicontinuous phase technology to a cosmetic product and clearly seems to provide the best conditions for subsequent skin care, meaning that it is suitable for the first step in the skincare process.     

Image analysis to quantify histological and immunofluorescent staining of ex vivo skin and skin cell cultures

Image processing steps and analysis techniques were developed for the quantification of photomicrographs obtained from light and fluorescence microscopy. The substrates examined were either skin cell cultures, such as normal human keratinocytes (NHK) or fibroblasts, or ex vivo skin sections. Examples of the analyses are provided for the comparison of skincare active ingredient treated samples vs. placebo to demonstrate the utility of the methods to quantify and provide numerical data for a procedure that is typically qualitative in nature and based on observations by a histologist. Quantifiable experiments that are discussed include: Fontana Masson staining for melanin expression; Nile red staining to detect cellular lipid droplets; nuclei staining with diamidino‐phenylindole (DAPI); and immunofluorescent staining of protein expression with a primary antibody directed against the protein (antigen) and a secondary antibody tagged with a fluorescent dye (Alexa Fluor 488) against the primary antibody.     

Gene editing and genetic engineering approaches for advanced probiotics: A review

The applications of probiotics are significant and thus resulted in need of genome analysis of probiotic strains. Various omics methods and systems biology approaches enables us to understand and optimize the metabolic processes. These techniques have increased the researcher's attention towards gut microbiome and provided a new source for the revelation of uncharacterized biosynthetic pathways which enables novel metabolic engineering approaches. In recent years, the broad and quantitative analysis of modified strains relies on systems biology tools such as in silico design which are commonly used methods for improving strain performance. The genetic manipulation of probiotic microorganisms is crucial for defining their role in intestinal microbiota and exploring their beneficial properties. This review describes an overview of gene editing and systems biology approaches, highlighting the advent of omics methods which allows the study of new routes for studying probiotic bacteria. We have also summarized gene editing tools like TALEN, ZFNs and CRISPR-Cas that edits or cleave the specific target DNA. Furthermore, in this review an overview of proposed design of advanced customized probiotic is also hypothesized to improvise the probiotics.     

Dietary Amino Acids and the Gut‐Microbiome‐Immune Axis: Physiological Metabolism and Therapeutic Prospects

Dietary amino acids (AAs) are not only absorbed and metabolized by enterocytes but also available to the microbiota in the gut in mammals. In addition to serving as the materials for protein synthesis, AAs can act as precursors for numerous metabolic end products in reactions involving the intestinal mucosa and microbiota. After penetrating the epithelial barrier, microbial metabolites can enter and accumulate in the host circulatory system, where they are sensed by immune cells and then elicit a wide range of biological functions via different receptors and mechanisms. Some intestinal bacteria can also synthesize certain AAs, implying that the exchange of AAs between hosts and microorganisms is bidirectional. Changes in AA composition and abundance can affect AA‐metabolizing bacterial communities and modulate macrophages and dendritic cells via toll‐like receptors (TLRs), autoinducer‐2 (AI‐2), and NOD‐like receptors (NLRs), and also regulate the gut‐microbiome‐immune axis via aryl hydrocarbon receptor (AhR), serotonin/5‐hydroxytryptamine (5‐HT), and other signaling pathways, all of which play critical roles in regulating the intestinal mucosal immunity and microbiota directly or indirectly, contributing to intestinal homeostasis. Therefore, the current findings of the effects of certain functional AAs on the gut‐microbiome‐immune axis are reviewed, illustrating signaling pathways of tryptophan (Trp), glutamine (Gln), methionine (Met), and branched‐chain AAs (BCAAs) in the intestinal barrier and regarding immunity via crosstalk with their receptors or ligands. These findings have shed light on the clinical applications of dietary AAs in improving gut microbiota and mucosal immunity, therefore benefiting the gut as well as local and systemic health.     

Gut Microbiome Analysis for Personalized Nutrition: The State of Science

Whereas most concepts of personalized nutrition (PN) in the past, included genotyping, recent years have brought new approaches that include microbiome analysis to optimize recommendations for diet and lifestyle changes. The new approach, offered by companies, that microbiome analysis provides a real benefit to either more concise recommendations or for increased compliance to PN, is largely lacking scientific validation. Although the microbiome field shows enormous proliferation, it has some major flaws that make its use in the public health domain currently critical. Starting with the quality and representative character of the stool samples, its processing and analysis as well as assembly of metagenome data and the interpretation. Moreover, there is still no consensus of what constitutes a “normal/healthy” microbiome, nor what features characterize a dysbiotic microbiome. And, based on hundreds of individual parameters and environmental factors, the intestinal microbiome shows a huge variability and consequently changing one factor—such as food intake—is likely to have a limited impact in achieving optimized health. The present review intends to summarize the state of consolidated knowledge on human gut microbiome in the context of diet and disease, its key features, and its influencing factors as well as its “add-on” quality for PN offers.     

Coenzyme Q(10) enhances dermal elastin expression, inhibits IL-1α production and melanin synthesis in vitro

Coenzyme Q(10) (CoQ(10) ) is a well-known antioxidant and has been used in many skincare products for anti-ageing purpose. However, the molecular mechanisms of CoQ(10) function in skin cells are not fully understood. In this paper, we compared the effects of CoQ(10) on primary human dermal fibroblasts from three individuals, including adult. We demonstrated that CoQ(10) treatment promoted proliferation of fibroblasts, increased type IV collagen expression and reduced UVR-induced matrix metalloproteinases-1 (MMP-1) level in embryonic and adult cells. In addition, CoQ(10) treatment increased elastin gene expression in cultured fibroblasts and significantly decreased UVR-induced IL-1α production in HaCat cells. Taken together, CoQ(10) presented anti-ageing benefits against intrinsic ageing as well as photo damage. Interestingly, CoQ(10) was able to inhibit tyrosinase activity, resulting in reduced melanin content in B16 cells. Thus, CoQ(10) may have potential depigmentation effects for skincare.     

Non-gene-editing microbiome engineering of spontaneous food fermentation microbiota—Limitation control,design control,and integration

Non-gene-editing microbiome engineering (NgeME) is the rational design and control of natural microbial consortia to perform desired functions. Traditional NgeME approaches use selected environmental variables to force natural microbial consortia to perform the desired functions. Spontaneous food fermentation, the oldest kind of traditional NgeME, transforms foods into various fermented products using natural microbial networks. In traditional NgeME, spontaneous food fermentation microbiotas (SFFMs) are typically formed and controlled manually by the establishment of limiting factors in small batches with little mechanization. However, limitation control generally leads to trade-offs between efficiency and the quality of fermentation. Modern NgeME approaches based on synthetic microbial ecology have been developed using designed microbial communities to explore assembly mechanisms and target functional enhancement of SFFMs. This has greatly improved our understanding of microbiota control, but such approaches still have shortcomings compared to traditional NgeME. Here, we comprehensively describe research on mechanisms and control strategies for SFFMs based on traditional and modern NgeME. We discuss the ecological and engineering principles of the two approaches to enhance the understanding of how best to control SFFM. We also review recent applied and theoretical research on modern NgeME and propose an integrated in vitro synthetic microbiota model to bridge gaps between limitation control and design control for SFFM.     

Invited review: Microbiota of the bovine udder: Contributing factors and potential implications for udder health and mastitis susceptibility

Various body sites of vertebrates provide stable and nutrient-rich ecosystems for a diverse range of commensal, opportunistic, and pathogenic microorganisms to thrive. The collective genomes of these microbial symbionts (the microbiome) provide host animals with several advantages, including metabolism of indigestible carbohydrates, biosynthesis of vitamins, and modulation of innate and adaptive immune systems. In the context of the bovine udder, however, the relationship between cow and microbes has been traditionally viewed strictly from the perspective of host-pathogen interactions, with intramammary infections by mastitis pathogens triggering inflammatory responses (i.e., mastitis) that are often detrimental to mammary tissues and cow physiology. This traditional view has been challenged by recent metagenomic studies indicating that mammary secretions of clinically healthy quarters can harbor genomic markers of diverse bacterial groups, the vast majority of which have not been associated with mastitis. These observations have given rise to the concept of “commensal mammary microbiota,” the ecological properties of which can have important implications for understanding the pathogenesis of mastitis and offer opportunities for development of novel prophylactic or therapeutic products (or both) as alternatives to antimicrobials. Studies conducted to date have suggested that an optimum diversity of mammary microbiota is associated with immune homeostasis, whereas the microbiota of mastitic quarters, or those with a history of mastitis, are considerably less diverse. Whether disruption of the diversity of udder microbiota (dysbiosis) has a role in determining mastitis susceptibility remains unknown. Moreover, little is known about contributions of various biotic and abiotic factors in shaping overall diversity of udder microbiota. This review summarizes current understanding of the microbiota within various niches of the udder and highlights the need to view the microbiota of the teat apex, teat canal, and mammary secretions as interconnected niches of a highly dynamic microbial ecosystem. In addition, host-associated factors, including physiological and anatomical parameters, as well as genetic traits that may affect the udder microbiota are briefly discussed. Finally, current understanding of the effect of antimicrobials on the composition of intramammary microbiota is discussed, highlighting the resilience of udder microbiota to exogenous perturbants.     

The human gut microbiome,diet, and health: “Post hoc non ergo propter hoc”

The gastro-intestinal microbiome has become the subject of intensive research, which is beginning to elucidate its roles in human health. It is becoming increasingly recognised that gut microbiota plays a part in regulating human immune homeostasis and metabolism, which gives rise to novel opportunities for preventative and treatment strategies. The key challenge in this field is the ability to define causality in the relationship between nutrition, microbiota and host health. In this commentary we argue for an increased focus on cause-and-effect relationships within studies that relate to the human microbiome in health and predispositions to disease. With the right experimental models, data accessibility infrastructure and advanced machine learning tools, causal relationships among components of complex host-microbiome systems can be elucidated.     

Drivers that establish and assembly the lactic acid bacteria biota in cheeses

BackgroundCheeses are inherently microbiologically and biochemically dynamic. Numerous biotic and abiotic drivers govern the establishment and assembly of a core microbiota in cheese, which, for internally-ripened cheeses, having an intermediate to long period of ripening, consists of starter and non-starter lactic acid bacteria (SLAB and NSLAB). The management of this dynamic ecosystem has to consider this core as a super-organism, which results from the sums of microbial metabolisms and interactions among individual microbes.Scope and approachThis review focuses on all presumptive drivers, raw and pasteurized milk, farming system and house microbiota, and intrinsic and extrinsic factors during cheese manufacture and ripening, which qualitatively and mainly depending on the farm management system and cheese variety may influence the populations of SLAB and NSLAB. The interactions between these two microbial groups are described also.Key findings and conclusionsThe cheese ecosystem shows a variable flux of its core microbiota from milking through manufacture to ripening. Many and diverse drivers establish and assembly the lactic acid bacteria biota. If such drivers are efficient to guarantee microbial and cheese diversities, on the other hand, their control is the fundamental pre-requisite to synchronize and balance microbiological events. The methodological approaches (e.g., omics techniques and integrated system biology) have markedly improved to concretize this ambitious goal. Facing and improving the knowledge on the main drivers, the current step should focus on a unique puzzle of coexisting species/biotypes likely a super-organism, whose guide has to consider all casehardened microbial elements.     

Current and future experimental approaches in the study of grape and wine polyphenols interacting gut microbiota

Interactions between polyphenols and gut microbiota are indeed a major issue of current interest in food science research. Knowledge in this subject is progressing as the experimental procedures and analysis techniques do. The aim of this article is to critically review the more leading-edge approaches that have been applied so far in the study of the interactions between grape/wine polyphenols and gut microbiota. This is the case of in vitro dynamic gastrointestinal simulation models that try to mitigate the limitations of simple static models (batch culture fermentations). More complex approaches include the experimentation with animals (mice, rats, pigs, lambs and chicks) and nutritional intervention studies in humans. Main advantages and limitations as well as the most relevant findings achieved by each approach in the study of how grape/wine polyphenols can modulate the composition and/or functionality of gut microbiota, are detailed. Also, common findings obtained by the three approaches (in vitro, animal models and human nutritional interventions) such as the fact that the Firmicutes/Bacteroidetes ratio tends to decrease after the feed/intake/consumption of grape/wine polyphenols are highlighted. Additionally, a nematode (Caenorhabditis elegans) model, previously used for investigating the mechanisms of processes such as aging, neurodegeneration, oxidative stress and inflammation, is presented as an emerging approach for the study of polyphenols interacting gut microbiota. © 2020 Society of Chemical Industry     

The human microbiome and metabolomics: Current concepts and applications

The mammalian gastrointestinal tract has co-developed with a large number of microbes in a symbiotic relationship over millions of years. Recent studies indicate that indigenous bacteria are intimate with the intestine and play essential roles in health and disease. In the quest to maintain a stable niche, these prokaryotes influence multiple host metabolic pathways, resulting from an interactive host–microbiota metabolic signaling and impacting strongly on the metabolic phenotypes of the host. Since dysbiosis of the gut bacteria result in alteration in the levels of certain microbial and host co-metabolites, identifying these markers could enhance early detection of diseases. Also, identification of these metabolic fingerprints could give us clues as to how to manipulate the microbiome to promote health or treat diseases. This review provides an overview of our current knowledge of the microbiome and metablomics, applications and the future perspectives.     

First skin-physiological tests in weightlessness in the ISS space station

Citation: IFSCC Magazine , 11 (2008) (3) 231–238
A prolonged stay in weightlessness induces several medical alterations of the human body and also results in impairment of the skin. The stratum corneum, epidermal barrier as well as other skin compartments are affected in terms of their susceptibility to dryness, desquamation and pruritus. This can lead, for example, to wound healing disorders. Skin physiological tests were performed on the skin of an astronaut during the ASTROLAB-Mission within the Skin Care program initiated by the ESA. The skin was analyzed before, partly during and after the mission. In addition, the tests were repeated after 1 year. During the mission a control skin area was treated with a skincare product. The results showed corneal disturbance caused by environmental conditions, suboptimal skin cleansing and skin care. The observed effects were minimized by application of a skincare product. Measurements of the epidermis showed an accelerated rate of epidermal keratinization; skin elasticity was reduced distinctly and the sonographic examination showed a disaggregation of the cutis with hypoechoic areas. Additional measurements performed a year after the mission indicate that the verified alterations, which in a broader sense seem similar to skin ageing and appear as a time lapse process in weightlessness, are reversible. Further testing of the preventive efficacy of anti-ageing products from a cosmetic point of view would appear to be an appropriate objective for prospective long-term space missions.
Keywords:  Weightlessness, skin changes, hydration, TEWL, SELS (Visioscan^®), elasticity, US-B-scan     

玻尿酸在功能性纺织品中的应用

玻尿酸是一种天然安全、可降解的生物材料,同时具有保湿、修复等多种护肤功效。基于玻尿酸的特性开发护肤纺织品是近年来功能性纺织品的创新发展方向之一。文章介绍了玻尿酸的特点、玻尿酸纺织面料的制备及其应用情况以及玻尿酸含量的检测方法,以期为功能性纺织品的研究与开发提供参考。